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Antibacterial activityAbstract Double headed acyclo-C-nucleosides, 1,4-bis(3-mercapto-1H-1,2,4-triazol-5-yl)butane-
1,2,3,4-tetrol (6), 5,50-(1,2,3,4-tetrahydroxybutane-1,4-diyl)bis(1,3,4-oxadiazole-2(3H)-thione) (7),
and 1,4-bis(4-amino-5-mercapto-4H-1,2,4-triazol-3-yl)butane-1,2,3,4-tetrol (8) have been synthe-
sized from D-glucose (1) without protecting hydroxyl groups. Two steps synthesis leading to forma-
tion of 2,3,4,5-tetrahydroxyhexanedihydrazide (4) which is regarded as starting intermediates for
the synthesis of 6,7 and 8. Synthetic intermediates and ﬁnal products were appropriately character-
ized by IR, 1H NMR and 13C NMR. The products were tested in vitro against gram positive bac-
teria Staphylococcus aureus, Listeria inovanii and gram negative bacteria Klebsiella pneumoniae,
Salmonella sp., Escherichia coli and compared with the known antibiotic: amoxicillin + clavulanic
acid (AMC) and showed variable effects.
ª 2012 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
The modern structural features of nucleosides are somewhat
different from those present in poly-ribonucleotides RNA
and DNA (see Fig. 1), by means of variations in sugar, hetero-
cyclic moieties and the various modes of attachments betweenthe two major components (sugar and heterocycle) (Watson
and Crick, 1954).
The cyclic sugar residues have shown a lot of variations
such as the ring size (Nakamura et al., 1986; Furuta et al.,
1979; Singha et al., 2003) and oxygen’s ring has been replaced
by N, S, Se, CH2 and other elements (Evans et al., 2003; Prich-
ard et al., 2009; Brown et al., 2001). Moreover the open chain
sugars are now appearing quite often in the literature (Poonian
and Nowoswiat, 1977; Yosuzawa et al., 1987; Tsuchiya et al.,
1995) since the discovery of acyclovir (Schaeffer et al., 1978) as
acyclic (Rashad et al., 2005; Rybak et al., 2000) and seco-acy-
clo-nucleosides (Ashry and Kilany, 1998) to expand the scope
of the terms: nucleosides and nucleosides analogues may be
schematically presented in Fig. 2.
R = H or OH 
O
R
HOH2C Het. Cycl. Het. Cycl. : Purine or pyrimidine
derivatives
OH
Figure 1 A classical structural representation of nucleosides.
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clic. In addition to pyrimidine andpurine derivatives, the hetero-
cyclic part is now including almost all kinds of heterocycles such
as oxadiazoles (Belkadi andOthman, 2006), thiadiazoles (Paolo
et al., 1996), triazoles (Awad and El Ashry, 1998) and others
(Cappellacci et al., 1997) are utilized at present in the synthesis
of various nucleosides due to the biological effects of various
kinds of heterocycles (Kalluraya et al., 1996; Holla et al., 1996).
The third emergent feature in structural modiﬁcation is the
different modes of attachments between sugar and heterocyclic
residues. The classical sugar –N-heterocyclic bridge is known
to comprise –C-heterocyclic (Jin and Hong, 2005), –S-heterocy-
clic (Talukdar et al., 2007), –O-heterocyclic (Marin˜o and Mar-
ino, 2005) functions and others (Lu et al., 2009).
The fourth modiﬁed structural feature includes the number
of the nucleobases attaching to sugar(s) molecule(s). A lot of
variations and kinds of nucleosides with dinuclear nucleosides
(Kasˇnar et al., 1993; Casiraghi et al., 1992), double-headed
nucleosides (Klein and Steglich, 1989) and others were also re-
ported (Jaffer et al., 2010; Shuto et al., 1999) (see for instance
Fig. 3).
The wide occurrences of heterocyclic compounds in bioac-
tive natural products and pharmaceuticals have made them as
important synthetic targets. The 1,3,4-oxadiazoles and 1,2,4-
triazoles represent classes of heterocyclic compounds of great
importance in biological chemistry (Demirbas, 2005; Amir
and Shikha, 2004; El Ashry et al., 2000; Demirbas et al., 2004).
The literature of the new kinds of nucleosides is increasing
particularly after the discovery of antiviral agent ‘‘acyclovir’’
as well as those acting against herpes simplex virus infection
(Gold and Corey, 1987; McKendrick, 1986).
Various approaches to the synthesis of nucleosides from
carbohydrate moieties were reported in the literature such as
fusion of sugar moieties to functionalized nucleobases (Diek-
mann et al., 1993) or linking a metal salt of the heterocycle
with a sugar halide (Kazimierczuk et al., 1984) or combination
of a heterocycle and sugar in the presence of a Lewis acid
(Wittenburg, 1964). Most of these methods involve protection
and deprotection of the OH groups.Nucleosides and nucleosides ana
Cyclic nucleosides 
x Het. Cycl.
Het.
Acyclo-nucl
x-acyclo-y-nuc
x-cyclo-y-nucleosides 
n
; x = O,N,S,C,Si,PHet. Cycl. = y
Figure 2 A proposed classiﬁcation for nIn this communication we would like to present a conve-
nient method for the synthesis of double headed nucleoside
using the spontaneous lactonization reaction as a step protect-
ing method within the synthetic pathway.
2. Experimental
2.1. General
All reactions were monitored by TLC analysis (silica gel for
TLC supplied by MERCK), iodine was used for visualization.
The melting points were measured with a BU¨CHI 540 melting
point apparatus and are uncorrected. The IR spectra exhibited
as wave number (m cm1) were recorded using KBr discs in a
JASCO V-530 spectrophotometer at the University of Oran,
Es-Senia, Algeria. The 1H NMR and 13C NMR (250 MHz)
spectra in DMSO-d6 exhibited as ppm, were recorded at the
University of Oran, Es-Senia (Algeria). Microorganisms in this
study were supplied by the university hospital of Oran and
identiﬁed by the laboratory of applied microbiology, Univer-
sity of Oran Es-Senia (Algeria). The Mueller Hinton medium
was supplied by Difco.
2.2. Chemical synthesis
2.2.1. D-Glucaro-1,5:6,3-dilactone (3)
Fuming nitric acid (31.0 mL) was heated to 55–60 C and D-
Glucose (1) (10.0 g, 55.5 mmol) was added in small batches
over a period of 10 min with an aid of magnetic stirring. A
vigorous exothermic reaction started taking place. The reac-
tion vessel was immerged into an ice-bath until vigorous
reaction seized. The reaction mixture then heated to 55–
60 C for 90 min. After cooling, the excess of nitric acid
was removed under vacuum and ether was added to the
remainder of the solution. A crystalline material was formed,
ﬁltered and washed with ether/dichloromethane 3:1 (v:v). The
solid was recrystallized from methanol to give D-glucaro-
1,5:6,3-dilactone (3). Colourless crystals, yield 45%, mp
80 C, IR (mmax, cm1): 3490 (OH), 1783 (C‚O, c-lactone),
1747 (C‚O, d-lactone). 1H NMR (250 MHz, DMSO-d6),
dH 4.47 (d, 1H, C-5–H), 4.42 (dd, 1H, C-3–H), 4.32 (d,
1H, C-2–H), 4.25 (dd, 1H, C-4–H), 4.21 (s, 1H, OH), 4.18
(s, 1H, OH). 13C NMR (250 MHz, DMSO-d6), dC 176.42
(C-6), 172.18 (C-1), 80.51 (C-5), 72.49 (C-3), 70.74 (C-2),
69.86 (C-4).logues
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The dilactone (3) (1.0 g, 5.74 mmol) was dissolved in ethanol
(40.0 mL). Hydrazine hydrate 64% (5.0 mL) was added drop
wise, a precipitate was formed immediately. The colloidal
mixture was agitated for further 30 min. The precipitate was
ﬁltered, washed with an iced cooled ethanol and recrystallized
from water. Yellow crystals, yield 86%, mp 122 C, IR (mmax,
cm1): 3431 (OH), 3362 (NH), 1629 (O‚C–N), 1616
(O‚C–N).
2.2.3. 2,20-(2,3,4,5-Tetrahydroxy-1,6-dioxohexane-1,6-
diyl)dihydrazinecarbothioamide (5)
The dihydrazide (4) (1.0 g, 4.2 mmol) was dissolved in H2O
with stirring. Ammonium thiocyanate (1.40 g, 18.6 mmol)
and HCl (30 mL, 37%) were added to the mixture. The solu-
tion was reﬂuxed on a water bath for 8 h at 80 C. Excess sol-
vent was evaporated to almost dryness and the crystalline solid
was ﬁltered off and recrystallized from methanol to afford
compound 5. Brown crystals, yield 88.6%, mp 100 C, IR
(mmax, cm
1): 3442 (OH), 3196 (NH), 1624 (CO–N), 1382
(C‚S).
2.2.4. 1,4-Bis(3-mercapto-1H-1,2,4-triazol-5-yl)butane-1,2,3,4-
tetrol (6)
2.2.4.1. Method A: Synthesis in ethanol.
Dihydrazinecarbothioamide (5) (1.0 g, 2.8 mmol) was dis-
solved in ethanol (40.0 mL) and added to solution of NaOH
(0.33 g, 8.25 mmol) in ethanol (40 mL). A precipitate was
formed immediately. The colloidal mixture was agitated for
further 30 min. The precipitate was ﬁltered, and recrystallized
from water. Yellow crystals, yield 84.4%, mp 72 C, IR (mmax,
cm1): 3414 (OH), 3300 (NH), 2536 (SH), 1619 (C‚N).
2.2.4.2. Method B: synthesis in water. Dihydrazinecarbothioa-
mide (5) (1.0 g, 2.8 mmol) was dissolved in water (40.0 mL)
and added to solution of NaOH (0.33 g, 8.25 mmol) in water
(10 mL) .The mixture was reﬂuxed for 8 h on a water bath at
80 C. After cooling, excess solvent was removed in vacuum.
The product was collected and crystallized from ethyl acetate
and recrystallized from methanol to afford compound 6. Yel-
low crystals, yield 88.0%, mp 72 C, IR (mmax, cm1): 3427
(OH), 3311 (NH), 2529 (SH), 1638 (C‚N). 1H NMR(250 MHz, DMSO-d6), dH 13.93 (s, 1H, –NH), 12.01 (s, 1H,
–NH), 8.66 (s, 1H, OH), 8.21 (s, 1H, OH), 4.45 (s, 1H,
–SH), 4.30 (s, 1H, OH), 4.21 (s, 1H, OH), 4.08 (d, 1H, C-1–
H or C-4–H); 3.96 (dd, 1H, C-2–H or C-3–H); 3.90 (d, 1H,
C-1–H or C-4–H); 3.83 (dd, 1H, C-2–H or C-3–H). 13C
NMR (250 MHz, DMSO-d6), dC 182.01 (C–SH); 173.52
(C‚N); 161.37 (C-2 and C-3); 140.87 (C-1 and C-4).
2.2.5. 5,50-(1,2,3,4-Tetrahydroxybutane-1,4-diyl)bis(1,3,4-
oxadiazole-2(3H)-thione) (7)
Dihydrazide (4) (1.0 g, 4.2 mmol) dissolved in water (40.0 mL)
was added to a solution of NaOH (1.0 g, 25 mmol) in water
(10.0 mL) and CS2 (30.0 mL). The reaction mixture was heated
under reﬂux at 80 C for 8 h. After cooling, excess solvent was
removed under vacuum and the remainder of the solution was
acidiﬁed with dil. HCl (10%) to pH 5. A solid was ﬁltered off
and washed with ethyl acetate to dissolve the organic products.
The washing solution upon standing overnight at room tem-
perature gave crystals which were recrystallized from chloro-
form/methanol (2:1, v:v) to afford compounds (7). Yellow
crystal, yield 76.3%, mp 159 C, IR (mmax, cm1): 3424 (OH),
3241(NH), 1618 (C‚N), 1381(C‚S), 1042 (C–O–C). 1H
NMR (250 MHz, DMSO-d6), dH 8.90 (s, 1H, –NH), 4.31 (s,
1H, OH), 4.21 (s, 1H, OH), 3.92 (d, 1H, C-1–H or C-4–H),
3.73 (dd, 1H, C-2–H or C-3–H), 3.63 (d, 1H, C-1–H or C-4–
H), 3.50 (s, 1H, OH), 3.43 (dd, 1H, C-2–H or C-3–H), 3.16
(s, 1H, OH). 13C NMR (250 MHz, DMSO-d6), dC 173.18
(C‚S), 151.88 (C‚N), 73.11 (C-2 and C-3), 65.98 (C-1 and
C-4).
2.2.6. 1,4-Bis(4-amino-5-mercapto-4H-1,2,4-triazol-3-
yl)butane-1,2,3,4-tetrol (8)
The compound 7 (1.0 g, 3.1 mmol) dissolved in EtOH
(80.0 mL) and hydrazine hydrate 64% (5.0 mL) were heated
under reﬂux on a water bath for 8 h at 90 C. Excess solvent
was evaporated and the remaining solid/liquid mixture was ﬁl-
tered off and washed with ethyl acetate to give 8 which was
recrystallized fromMeOH/H2O (2:1, v:v). Brown crystals, yield
72.2%, mp 142.7 C, IR (mmax, cm1): 3432 (OH), 3315 (NH),
2621 (SH), 1622 (C‚N). 1H NMR (250 MHz, DMSO-d6), dH
8.878 (s, 1H, NH), 8.828 (s, 1H, NH), 8.408 (s, 1H, NH),
8.223 (s, 1H, NH), 5.646 (s, 4H, 4 OH), 4.198 (s, 2H, 2 SH),
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C-3–H); 3.462 (d, 1H, C-1–H or C-4–H); 3.403 (dd, 1H, C-2–
H or C-3–H). 13C NMR (250 MHz, DMSO-d6), dC 181.598
(C–SH); 165.942 (C‚N); 142.457 (C-2 and C-3); 140.917 (C-
1 and C-4).
2.3. Antibacterial susceptibility testing
A disc diffusion assay according to the standard protocols
(CLSI, 2006; NCCLS, 2003, 2005) was used to determine the
susceptibility of two gram positive bacteria Staphylococcus
aureus ATCC 25923, Listeria inovanii ATCC 19119 and gram
negative bacteria Klebsiella pneumoniae ATCC 700603, Salmo-
nella sp., Escherichia coli ATCC 25922 and using the known
antibiotic amoxicillin + clavulanic acid combination (AMC
20/10 lg) as the reference. The bacterial suspension turbidity
was adjusted to 0.5 McFarland, and then the suspensions were
spread with a sterile cotton swab conﬂuent over the entire sur-
face of Mueller Hinton agar (Merck, Germany).
The ﬁlter paper disc method was performed in duplicate
using fresh Mueller Hinton agar medium. This agar medium
was inoculated with 0.5 mL of cultures containing about 106
CFU mL1. Filter paper discs (5 mm diameter) saturated with
solution of each compound (concentration 30 lg/mL) were
placed on the indicated agar media. The incubation time was
24 h at 37 C. The blank test disc with DMSO was used. Inhib-
itory activity was evaluated by measuring the diameter of clear
zone observed around the disc (in mm).
The minimum inhibition concentrations (MIC) test. Each
1 mL of the original concentration (30 lg mL1) in DMSO
of the compounds 4, 6, 7 and 8 was diluted with DMSO for
ﬁve times in test tubes to 15, 7.50, 3.75, 1.875, and
0.94 lg mL1. The optical density at 600 nm was measured
at 0 h, 18 h, 24 h and 48 h.
3. Results and discussion
3.1. Synthesis
The double headed acyclo-C-nucleosides 6, 7 and 8 have been
synthesized by a common pathway as described in scheme 1.
Oxidation of D-glucose (1) by fuming nitric acid revealed the
formation of D-glucaro-1,5:6,3-dilactone (3) as shown by IR
spectrum. It exhibited two carbonyl absorption bands at
1783 cm1 attributed to ﬁve member ring lactone and another
one at 1747 cm1 assigned to six member ring lactone (Pretch
et al., 2000a,b,c p. 265) occurred from spontaneous lactoniza-Table 1 Antibacterial activity-sensitivity testing of compounds: zon
Compounds* Gram positive bacteria
S. aureus L. inovanii
AMC 30 16
3 – –
4 36 16
5 – –
6 – –
7 16 14
8 22 –
For: AMC (amoxicillin + clavulanic acid combination) SP 18 mm; I=
* Concentration 30 lg mL1. Abbreviations: S, susceptible; I, intermediation of D-glucaric acid (2) between C-1–C-5 and C-6–C-3.
There is another hypothetical possibility of forming two lac-
tone rings in 2 which may take place between C-1–C-4 and
C-6–C-3 leading to double ﬁve member ring lactone (30) which
expected to show only one carbonyl absorption in IR at the re-
gion 1800 cm1 (Pretch et al., 2000a,b,c, p. 265). However,
13C NMR showed two signals at 176.43 and 172.19 ppm
attributed to C6 and C1 respectively (Pretch et al., 2000a,b,c,
p. 104). These differences in IR and 13C NMR suggested that
there is a formation of two lactone rings of different sizes. Re-
sults of the oxidation reaction of D-glucose was realized to be
sensitive to the concentration of nitric acid, heating tempera-
ture and time length of the reaction, since oxalic acid was re-
sulted in several cases.
The dihydrazide (4) was obtained in 86% yield by treatment
of dilactone (3) with hydrazide hydrate 64%. The IR spectra
showed two carbonyl bands at 1629 cm1 and 1616 cm1
attributed to the two hydrazide groups. The slight difference
in carbonyl absorptions may be due to the effect of strong
intramolecular hydrogen bonding (Pretch et al., 2000a,b,c, p.
265).
The dihydrazinecarbothioamide (5) was obtained from 4 by
treatment with ammonium thiocyanate and HCl under reﬂux
conditions to give the compound 5 in a good yield 88.6%.
The IR spectrum exhibited characteristic bands at 1624 cm1
assigned to (CO–N) and at 1382 cm1 assigned to (C‚S)
(Pretch et al., 2000a,b,c, p. 265).
The bis-triazole (6) was obtained by reaction of 5withNaOH
in water or ethanol. In water solution the reaction mixture was
reﬂuxed for 8 h at 80 C to give very good yield 88%of 6while in
ethanol the cyclization had taken place spontaneously at room
temperature in a yield of about 84.4%. IR and 1H NMR sug-
gested that the compound 6 existed as the ene-thiol form (Pretch
et al., 2000a,b,c, p. 186). Further support for the thiol form came
from IR and 1H NMR which exhibited a characteristic band at
2536 cm1 and a signal around 4.46 ppm where the S–H is nor-
mally shown.
For the preparation of the bis-oxadiazole (7), the dihydra-
zide (4) was heated with an aqueous solution of NaOH and
CS2 under reﬂux conditions followed by acidiﬁcation with
HCl to give a yellowish crystalline product 7 in a moderate
yield 76.3%. The IR spectrum exhibited the absorptions at
1618 cm1 for (C‚N), 1381 cm1 characteristic of (C‚S),
and 1042 cm1 for (C–O–C) (Pretch et al., 2000a,b,c, p. 265).
The position of the (C‚N) band suggested that the oxadiazole
existed as the thione tautomer rather than the ene-thiol form.
Further support for the thione form came from 1H NMR spec-e of inhibition (in mm).
Gram negative bacteri
K. pneumoniae Salmonella sp. E. coli
18 24 18
– – –
18 14 16
– – –
14 – –
– – –
– – 14
14–17 mm; R 6 13 mm.
te; R, resistant.
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Scheme 1 Common pathway to the synthesis of compounds 6, 7 and 8.
Table 2 Antibacterial activity of the compounds 4, 6, 7 and 8: MIC’s in lg/mL.
Compounds Gram positive bacteria Gram negative bacteria
S. aureus L. inovanii K. pneumoniae Salmonella sp. E. coli
4 0.94 1.875 1.875 1.875 1.875
6 – – 1.875 – –
7 1.875 1.875 – – –
8 0.94 – – – 1.875
MIC: Minimum inhibitory concentration.
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ton (Pretch et al., 2000a,b,c, p. 186).
The bis-4-amino-triazole (8) was prepared in moderate yield
72.2% by heating the compound 7 with hydrazine hydrate un-
der reﬂux conditions for 8 h. The IR spectrum showed the
characteristic band at 3431 cm1, 3315 cm1, 2621 cm1 and
1622 cm1 for (OH), (NH), (SH) and (C‚N) respectively
(Pretch et al., 2000a,b,c, p. 265). The 1H NMR supported
the structure 8 by exhibiting four singlets between
8.87ﬁ8.22 ppm attributed to two NH2 groups. (OH) groups
appeared as singlet at 5.64 ppm. In addition, SH signal at
4.19 ppm was also present as singlet (Pretch et al., 2000a,b,c,
p. 186). 13C NMR conﬁrmed the structure of 8 by revealing
signals at 181.59 ppm attributed to (C–SH) and 165.94 ppm
for (C‚N) (Pretch et al., 2000a,b,c, p. 104).3.2. Antibacterial tests
The inhibitory effect of the compounds 3, 4, 5, 6, 7 and 8 in
DMSO (10% v:v) was tested upon in vitro against gram po-
sitive bacteria S. aureus ATCC 25923, L. inovanii ATCC
19119 and gram negative bacteria K. pneumoniae ATCC
700603, Salmonella sp., E. coli ATCC 25922. DMSO which
is known as bacterial static in the above mentioned concen-
tration was used as negative control and standard discs
(Mast Diagnostics, UK) saturated with known antibiotic:
amoxicillin + clavulanic acid (AMC) as positive control
were applied. After incubation at 37 C for 24 h, the zone
of inhibition of growth around each disc was measured in
millimetres and zone diameters were interpreted in accor-
dance with CLSI and NCCLS guidelines (National Commit-
A convenient new synthesis, characterizationand antibacterial activity S1845tee for Clinical and Laboratory Standards Villanova, 1997;
Clinical and Laboratory Standards Institute, 2007).
The experiments were performed in duplicates and the aver-
age results are summarized in Table 1.
The screening results in Table 1 indicate that all compounds
under study showed variable effects upon gram positive and
gram negative bacteria.
Compounds 3 and 5 were found to be inactive against all
tests on bacterial species under study.
Compound 4 has a better inhibition effect than AMC
against S. aureus, a similar effect than AMC against L. inova-
nii, K. pneumoniae and an intermediate activity against the
other bacteria tested.
The bis-triazole (6) showed an intermediate effect on K.
pneumoniae.
The bis-oxadiazole (7) exhibited an intermediate activity
against gram positive bacteria S. aureus and L. inovanii.
The bis-4-amino-triazol (8) has a better inhibition effect
than AMC against S. aureus, but less than dihydrazide (4).
The compound 8 showed also an intermediate activity against
E. coli.
The minimum inhibitory concentrations (MIC) were deter-
mined for the active compounds 4, 6, 7 and 8 in triplicates
against the tested bacteria. The averages are shown in Table 2.
The dihydrazide (4) has exhibited its MIC at 0.94 lg mL1
on S. aureus and at 1.875 lg mL1 on other bacteria under test.
The bis-triazole (6) has exhibited its MIC at 1.875 lg mL1
on K. pneumoniae.
The bis-oxadiazole (7) has shown its (MIC) at
1.875 lg mL1 on the two gram positive bacteria S. aureus
and L. inovanii.
The bis-4-amino-triazol (8) has exhibited its MIC at
0.94 lg mL1 on S. aureus, and at 1.875 lg mL1 on E. coli.
All the newly synthesized compounds showed moderate
antibacterial activity, except dihydrazide (4) and bis-4-amino-
triazol (8) which observed the highest effect at lowest concen-
tration upon S. aureus. These ﬁndings concluded that the titled
compounds have the property to kill the microbes in some ex-
tent when compared with standard drug; it gives a future scope
to study the mechanism of action and would be worthy of fur-
ther investigation.
4. Conclusion
In conclusion, double headed C-nucleosides from unprotected
D-glucose were synthesized and their structures were deter-
mined and also assayed for their in vitro antibacterial activity.
This study should extend on anti-viral, antifungal and anti-
cancer tests because the literature gives enormously interesting
results on these subjects. Also tests on other bacteria should
also be included to widen the investigation.
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